A propensity matched case–control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator.

MLA

Honarbakhsh, S., et al. “A Propensity Matched Case–control Study Comparing Efficacy, Safety and Costs of the Subcutaneous vs. Transvenous Implantable Cardioverter Defibrillator.” International Journal of Cardiology, vol. 228, Feb. 2017, pp. 280–85. EBSCOhost, https://doi.org/10.1016/j.ijcard.2016.11.017.

APA

Honarbakhsh, S., Providencia, R., Srinivasan, N., Ahsan, S., Lowe, M., Rowland, E., Hunter, R., Finlay, M., Segal, O., Earley, M., Chow, A., Schilling, R., & Lambiase, P. (2017). A propensity matched case–control study comparing efficacy, safety and costs of the subcutaneous vs. transvenous implantable cardioverter defibrillator. International Journal of Cardiology, 228, 280–285. https://doi.org/10.1016/j.ijcard.2016.11.017

Chicago

Honarbakhsh, S., R. Providencia, N. Srinivasan, S. Ahsan, M. Lowe, E. Rowland, Rj Hunter, et al. 2017. “A Propensity Matched Case–control Study Comparing Efficacy, Safety and Costs of the Subcutaneous vs. Transvenous Implantable Cardioverter Defibrillator.” International Journal of Cardiology 228 (February): 280–85. doi:10.1016/j.ijcard.2016.11.017.